Related Experiment Video
Updated: May 5, 2026

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project
Published on: November 12, 2009
Virtual reality for insomnia and sleep improvements: a systematic review and meta-analysis
S Cerolini1, E Baldi1, M Rizzuti2
1Department of Human Sciences, Università degli Studi Guglielmo Marconi, Rome, Italy.
None:
Virtual reality (VR) interventions have been successfully used in the treatment of various mental health disorders, and recent research has begun to explore their application in sleep clinical settings. This systematic review and meta-analysis aims to synthesize the existing literature on intervention studies utilizing VR technologies to improve insomnia and sleep outcomes. A systematic search across PubMed, PsycINFO, and Scopus identified 48 studies for qualitative synthesis, with 8 included in quantitative analyses. Meta-analysis included a total of 299 participants, and it was conducted based on the sleep measures employed. Quantitative findings suggest that VR interventions are associated with improvements in sleep quality, as measured by the Pittsburgh Sleep Quality Index (PSQI). While the overall heterogeneity of included studies limits the strength of quantitative conclusions, qualitative synthesis indicates consistent and promising effects of VR-based interventions on sleep across both healthy and clinical populations. These findings underscore the need for rigorous, high-quality trials to further evaluate the efficacy of VR in enhancing sleep and its potential role in treating insomnia.
More Related Videos
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Insomnia
Multiple factors contribute...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Nightmares and Night Terrors
Nightmares...